Rare diseases
Investigational molecules
Locations
Back to Italy2 907 clinical trials in Legnano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis
ItalyStudy of rimegepant for preventing chronic migraine in adolescents aged 12 to 17 years
ItalyStudy of datopotamab deruxtecan with or without durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
ItalyStudy of tozorakimab to reduce exacerbations in former smokers with chronic obstructive pulmonary disease (COPD)
ItalyLong-term safety study of NNC6019-0001 for patients with transthyretin amyloid cardiomyopathy (ATTR-CM)
ItalyStudy of bitopertin to improve sunlight tolerance in adults with erythropoietic protoporphyria or X-linked protoporphyria
ItalyStudy of subcutaneous nivolumab with ipilimumab and chemotherapy in previously untreated patients with metastatic or recurrent non-small cell lung cancer
ItalyStudy of tarlatamab with durvalumab, carboplatin and etoposide versus standard treatment in patients with previously untreated extensive stage small cell lung cancer
ItalyLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
ItalyStudy of inhaled BX004 bacteriophage treatment for adults with cystic fibrosis who have chronic Pseudomonas aeruginosa lung infection
ItalyStudy of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.
ItalyStudy of rMenB+OMV NZ meningococcal group B vaccine immune response and safety in previously vaccinated healthy participants aged 10 to 20 years
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on Multiple Myeloma treatments, including innovative therapies for relapsed and refractory cases. Studies evaluating new drug combinations and treatment approaches for better patient outcomes.
Multiple ongoing trials testing various therapeutic combinations to improve survival rates.
Groundbreaking studies in lung cancer and breast cancer treatment, investigating novel immunotherapy combinations and targeted therapies.
Focus on personalized treatment approaches and biomarker-driven therapies.
Innovative research in chronic kidney disease and HIV management, exploring new treatment strategies and medication combinations.
Studies aimed at improving long-term patient outcomes and quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
